(Q33945890)

English

Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience (English)

1 reference

Europe PubMed Central

30 July 2017

magnetic resonance imaging

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

8

object named as

Won Jae Lee

1 reference

Europe PubMed Central

30 July 2017

author name string

Yulri Park

1

1 reference

Europe PubMed Central

30 July 2017

Seong Hyun Kim

2

1 reference

Europe PubMed Central

30 July 2017

Seung Hoon Kim

3

1 reference

Europe PubMed Central

30 July 2017

Yong Hwan Jeon

4

1 reference

Europe PubMed Central

30 July 2017

Jongmee Lee

5

1 reference

Europe PubMed Central

30 July 2017

Min Ju Kim

6

1 reference

Europe PubMed Central

30 July 2017

Dongil Choi

7

1 reference

Europe PubMed Central

30 July 2017

Heejung Kim

9

1 reference

Europe PubMed Central

30 July 2017

Ji Hyun Koo

10

1 reference

Europe PubMed Central

30 July 2017

Hyo Keun Lim

11

1 reference

Europe PubMed Central

30 July 2017

publication date

21 June 2010

1 reference

Europe PubMed Central

30 July 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Korean journal of radiology : official journal of the Korean Radiological Society

1 reference

Europe PubMed Central

30 July 2017

11

1 reference

Europe PubMed Central

30 July 2017

4

1 reference

Europe PubMed Central

30 July 2017

433-440

1 reference

Europe PubMed Central

30 July 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

1 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

5 July 2018

Hypointense hepatic lesions depicted on gadobenate dimeglumine-enhanced three-hour delayed hepatobiliary-phase MR imaging: differentiation between benignancy and malignancy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

5 July 2018

Comparison of gadobenate dimeglumine-enhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

5 July 2018

Management of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

5 July 2018

Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

5 July 2018

High field body MR imaging: preliminary experiences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

5 July 2018

Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

5 July 2018

Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

5 July 2018

Coil sensitivity encoding in MR imaging: advantages and disadvantages in clinical practice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

5 July 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

5 July 2018

Gadobenate dimeglumine (Gd-BOPTA). An overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

5 July 2018

Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

5 July 2018

Soluble-type hepatobiliary contrast agents for MR imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

5 July 2018

Liver contrast media for magnetic resonance imaging. Interrelations between pharmacokinetics and imaging.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

5 July 2018

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

5 July 2018

Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

5 July 2018

Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

29 October 2018

Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

29 October 2018

Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

29 October 2018

The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

29 October 2018

Superparamagnetic iron oxide-enhanced liver magnetic resonance imaging: comparison of 1.5 T and 3.0 T imaging for detection of focal malignant liver lesions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

29 October 2018

Diagnosis of small hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

29 October 2018

Preoperative depiction of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus triple-phase helical CT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

29 October 2018

Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

29 October 2018

Paired receiver operating characteristic curves and the effect of history on radiographic interpretation. CT of the head as a case study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2893314

29 October 2018

Hepatocellular carcinoma: are combined CT during arterial portography and CT hepatic arteriography in addition to triple-phase helical CT all necessary for preoperative evaluation?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20592927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On Comparisons of Sensitivity, Specificity and Predictive Value of a Number of Diagnostic Procedures

1 reference

https://pubmed.ncbi.nlm.nih.gov/20592927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility artefacts in NMR imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/20592927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/20592927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multihance clinical pharmacology: biodistribution and MR enhancement of the liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/20592927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/20592927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations

1 reference

https://pubmed.ncbi.nlm.nih.gov/20592927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3348/KJR.2010.11.4.433

1 reference

Europe PubMed Central

30 July 2017

release_rzav5q3jdjaevb5ojyhnndayy4

1 reference

https://api.fatcat.wiki/v0/release/rzav5q3jdjaevb5ojyhnndayy4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33945890&oldid=1870239984"